Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03444753 |
|---|---|
| Brief Title: | An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed |
| First Submitted : | February 20, 2018 |
| First Submitted that Met QC Criteria : | February 20, 2018 |
| First Posted : | February 23, 2018 |
| Last Update Submitted that Met QC Criteria : | May 17, 2022 |
| Last Update Posted : | May 23, 2022 |